America prepares for the logistical problem of distributing the anticovid vaccine

After the approval in at the very least 5 international locations of the world of a primary vaccine for covid-19, America is now making ready for the good logistical problem that may entail its transport, storage and distribution, amid the urgency to cease a virus that already leaves greater than 30 million contaminated and 770,000 useless on the continent, in keeping with EFE.

In a day of expectation for the approaching approval of the Pfizer vaccine within the US after the endorsement in Canada, the World Well being Group (WHO) reported this Friday that the variety of world circumstances of covid-19 rises to 69 , 1 million and the dying toll is round 1.57 million.

America, which exhibits a robust upward pattern in infections, continues to be essentially the most affected area, with some 30 million circumstances and greater than 770,000 deaths, in comparison with 21.4 million infections and 474,000 deaths on the European continent and 11, 2 million circumstances and 171,000 deaths in South Asia.

In line with information from Johns Hopkins College, the USA stays the nation with essentially the most infections and deaths (15.6 million circumstances and greater than 292,000 deaths); adopted by India, with 9.8 million positives and greater than 142,100 deaths; and Brazil, with 6.7 million infections and a few 180,000 deaths.

America: 30 million contaminated and greater than 770,000 deaths

Along with Brazil, the place at present it was alerted that the occupation of intensive care already exceeds 90% in lots of cities, two different Latin American international locations are among the many world prime ten in variety of circumstances: Argentina (ninth) and Colombia (tenth).

Argentina registers 1.48 million contaminated; Colombia studies 1.39 million infections; and Mexico 1.2 million. Then there are Peru (about 979,000 circumstances and 36,400 deaths), Chile (greater than 567,900 infections and 15,782 deaths) and, a lot additional again, Ecuador (200,765 contaminated and greater than 13,800 deaths).

Knowledge from the Inter-American Growth Financial institution (IDB) level to a excessive mortality fee in Latin America as a result of coronavirus, with 74 deaths per 100,000 inhabitants, whereas the world common is 21.

The truth is, two Latin American international locations stay among the many prime ten on this planet by way of deaths: Brazil (second, with about 180,000) and Mexico (fourth, with greater than 112,000). As well as, Argentina (greater than 40,400 deaths), Colombia (about 38,400) and Peru (about 36,400) rank 11, 12 and 13, respectively.

With this, America has greater than 30 million contaminated and round 770,000 deaths. Of that determine, within the Latin American and Caribbean area there are about 13.8 million circumstances (19.9% ​​of the worldwide complete) and about 466,000 deaths.

Expectation for vaccine approvals

The US authorities introduced this Friday that it’s “very shut” to approving the vaccine in opposition to covid-19 from the US pharmaceutical firm Pfizer, in order that the immunization marketing campaign might start on Monday or Tuesday of subsequent week.

If the Meals and Drug Administration (FDA) lastly decides to approve it, the USA will be part of the UK, Bahrain, Canada and Saudi Arabia, which have already given it the go-ahead.

The scenario is totally different for different nations since greater than 100 creating international locations, comparable to these in Latin America, lack companies able to finishing up these evaluations and rely upon the endorsement of the World Well being Group (WHO).

To this point, the WHO has obtained three dossiers of vaccine candidates and essentially the most superior analysis is the one developed by Pfizer along with the German biotechnology firm BioNTech.

The problem of deep freezing

The chief scientist of the WHO, Soumya Swaminathan, stated this Friday that within the coming weeks the group might subject an opinion on the emergency use of the primary vaccine, earlier than which America is already evaluating its logistical capability.

“There are fairly just a few challenges, however the primary one is that the vaccine has to protect its chilly chain from when it leaves the manufacturing facility, in air transport, arrival on the airport, storage in every nation, till when it’s lastly going to be vaccinated. the individual, “defined Daniel Rodríguez, director of Procurement and Provides of the Pan American Well being Group (PAHO / WHO).

“In any case, from leaving the manufacturing facility to the vacation spot airport, it can’t take greater than 72 hours. The connection needs to be super-fast, it can’t be misplaced at any connection level as a result of we danger dropping high quality,” he added to element that vaccines are transported on passenger planes.

In line with the businesses themselves, the dose administered by Pfizer must be saved at -70 levels Celsius, whereas that of the American firm Moderna might be saved for as much as 6 months at a temperature of 20 levels under zero.

“We don’t have one of these deep freezing, it isn’t a part of the common vaccination applications,” defined Cuauhtémoc Ruiz Matus, head of the PAHO Immunization Program, noting that for that reason some international locations within the area have signed agreements immediately with the laboratories.

Mexico, for instance, stated just a few days in the past that the 34.4 million vaccines in opposition to covid-19 that it’s going to obtain from Pfizer will probably be guarded by the pharmaceutical firm till the purpose of vaccination, with which the corporate will clear up the difficulties to maintain them deep-frozen. Whereas Panama works in opposition to the clock to construct 4 chilly rooms and purchase fifteen particular freezers.

Vaccines amid spike in infections

By way of the COVAX mechanism, some 180 international locations have assured preliminary doses with the WHO to cowl at the very least 3% of the inhabitants within the early levels of vaccine deployment, finally reaching 20% ​​of its inhabitants, sufficient to guard folks most in danger.

PAHO estimates that to vaccinate 20% of the area’s inhabitants, 273 million doses will probably be wanted (with a two-dose schedule at $ 10.55 / dose), at a projected value of $ 2,714,200,000.

The need for the vaccine grows as infections soar once more in international locations comparable to Cuba, Mexico or Brazil, the place even states like Sao Paulo and Rio de Janeiro introduced at present the reimplantation of timid social distancing measures.


The Federal Fee for the Safety in opposition to Sanitary Dangers (COFEPRIS) of Mexico has approved this Friday the emergency use of the candidate for the coronavirus vaccine from the pharmaceutical firm Pfizer, turning into the primary nation to take action within the Latin American area, in keeping with Europe. Press.

This has been communicated by the Undersecretary of Well being and Prevention, Hugo López-Gatell, and the fee itself by means of an announcement through which they reported that “the New Molecules Committee met on December 11, 2020, the place its 24 members voted they usually issued a positive opinion, unanimously, for its emergency use. “

With this approval, Mexico turns into the fourth nation on this planet to subject one of these authorization, after the UK, Canada and Bahrain, whereas the USA’ regulatory physique for medicines is on the verge of approval.

It could curiosity you

On the finish of November, Pfizer submitted the applying for the well being registration of its vaccine in opposition to COFEPRIS to COFEPRIS, and it’s anticipated that the primary doses will arrive within the subsequent few weeks to start inoculating the inhabitants.

On Tuesday, the well being authorities detailed how the nation’s vaccination technique will probably be, which can consist of 5 levels, which can final till June 2021 and March 2022.



Related Articles